Importantly, given that decreased AdipoR expression is a hallmark of obesity27, establishing ways to activate adiponectin/AdipoR signal is expected to be the key for definitive treatment of obesity-related diseases. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.